Carestream Health Earned 70 New Patents In 2024

Carestream Health earned 70 new patents in medical imaging in 2020 for advances in digital radiography, mobile imaging X-ray systems, and other healthcare technology areas. Carestream Health notes that twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.

“Carestream’s 2020 patents are 70 more proof points of our ability to develop pioneering digital imaging technologies that meet the evolving medical imaging needs of our customers worldwide,” said Eugene Shkurko, Intellectual Property Counsel at Carestream. “Our research and development team continually pursues innovations that have the potential to improve the delivery of care to benefit both patients and providers.”

Patents earned by Carestream’s scientists and engineers in 2020 include:

  • Technology advances in Carestream’s growing portfolio of radiology imaging detectors with processing capabilities to calibrate and correct X-ray images in the detector before transmission
  • 3-D image reconstruction methods
  • New medical image capture technologies related to long-length imaging using a single X-ray exposure for full spinal and extremity imaging; and
  • Mobile X-ray cart technology that enables bedside imaging in selectable modes: projection radiography, tomosynthesis and fluoroscopy.

Carestream’s broad product portfolio includes 2D and 3D digital medical imaging systems for general radiology and specialty areas such as pediatrics and orthopaedics (see video link), as well as digital laser imagers that output medical images to film.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”